Page last updated: 2024-10-19

melatonin and Carcinoma in Situ

melatonin has been researched along with Carcinoma in Situ in 1 studies

Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"Pravastatin was given orally (1 00 mg/kg) and melatonin was added to the water (20 μg/ml)."1.40Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model. ( Adamicová, K; Adamkov, M; Bojková, B; Chmelová, M; Kajo, K; Kapinová, A; Kassayová, M; Kružliak, P; Kubatka, P; Orendáš, P; Péč, M; Sadloňová, V; Stollárová, N; Výbohová, D, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orendáš, P1
Kubatka, P1
Bojková, B1
Kassayová, M1
Kajo, K1
Výbohová, D1
Kružliak, P1
Péč, M1
Adamkov, M1
Kapinová, A1
Adamicová, K1
Sadloňová, V1
Chmelová, M1
Stollárová, N1

Other Studies

1 other study available for melatonin and Carcinoma in Situ

ArticleYear
Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model.
    International journal of experimental pathology, 2014, Volume: 95, Issue:6

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma in Situ; Carci

2014